Detalles de la búsqueda
1.
Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis.
Clin Gastroenterol Hepatol
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423347
2.
Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
Dig Dis Sci
; 69(5): 1731-1738, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594429
3.
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials.
Clin Gastroenterol Hepatol
; 21(3): 723-731.e9, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35750249
4.
Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
Am J Gastroenterol
; 114(12): 1886-1893, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31688023
5.
Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.
Hepatol Commun
; 8(6)2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727685
6.
Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea.
Adv Ther
; 41(6): 2253-2266, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38619720
7.
Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
Clin Ther
; 45(3): 198-209, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36922331
8.
Impact of rifaximin use following an initial overt hepatic encephalopathy hospitalization on rehospitalization and costs.
J Med Econ
; 26(1): 1169-1177, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664993
9.
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States.
J Med Econ
; 24(1): 202-211, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33464935
10.
Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
Clin Transl Gastroenterol
; 11(3): e00144, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32352714
11.
Rifaximin has the potential to prevent complications of cirrhosis.
Therap Adv Gastroenterol
; 11: 1756284818800307, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30283499
12.
Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Therap Adv Gastroenterol
; 10(9): 689-699, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28932270
Resultados
1 -
12
de 12
1
Próxima >
>>